VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2020 | Front-line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced RCC

Michael Atkins, MD, Georgetown University, Washington, DC discusses the Phase II study of front line therapy with nivolumab and salvage nivolumab and ipilimumab in patients with advanced renal cell carcinoma (NCT03117309). This video was recorded via an online conference call with the Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter